Sizzling update why Cleveland BioLabs, Inc. (CBLI) shares surged on Friday night

0
1872
DPRO Stock
DPRO Stock

Cleveland BioLabs, Inc. (NASDAQ: CBLI) stock was tossed up almost 30% to $3.7 in the late hours on Friday after the reports that in connection with the merger of CBLI with Cytocom, the Lifshitz Law Firm, P.C. is investigating possible breaches of fiduciary duties. CBLI investors who wish to learn more about our investigation should complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Read More

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.

Sponsored

LEAVE A REPLY

Please enter your comment!
Please enter your name here